Active	Status	Sponsor type	Region	Phase	Filter
2 Active 6 Inactive 8 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Prevost, Gaëtan
REALIST, NCT03648554: Researching an Effect of GLP-1 Agonist on Liver STeatosis	Not yet recruiting	4	93	Europe	dulaglutide (TRULICITY®) 1.5 mg, reinforced dietary monitoring	Central Hospital, Nancy, France, Eli Lilly and Company	Diabetes Mellitus, Type 2, NASH - Nonalcoholic Steatohepatitis	09/23	03/24
PDF, NCT04533152: Prognostic Determinants in Patients With Diabetic Foot Ulcer.	Recruiting	N/A	1000	Europe, RoW		University Hospital, Bordeaux, Fondation Francophone pour la Recherche sur le Diabete	Diabetic Foot Ulcer	11/29	11/29
Gancel, Antoine
No trials found
Grall-Lerosey, Martine
No trials found